Carmine Therapeutics named as one of FierceBiotech’s “Fierce 15” Biotech Companies of 2020
Carmine Therapeutics has been named as one of FierceBiotech’s “Fierce 15” Biotech companies of 2020, designating it as one of the most promi
top of page
Jun 30, 2020
Carmine Therapeutics & Takeda Collaborate to Develop Novel Non-viral Gene Therapies
Carmine Therapeutics and Takeda Collaborate to Discover and Develop Rare Disease Gene Therapies Using Novel Red Blood Cell Extracellular...
Dec 10, 2019
Carmine Therapeutics won the Bristol-Myers Squibb’s 2019 Golden Ticket
Carmine Therapeutics is proud to announce that it has won the Bristol-Myers Squibb’s 2019 Golden Ticket for LabCentral. LabCentral is an...
Aug 30, 2019
Esco Ventures Announces the Launch of Carmine Therapeutics
30 August 2019 – Esco Ventures is pleased to announce the launch of Carmine Therapeutics and Carmine Therapeutics plans to establish a...
bottom of page